NIH-funded research NIH-funded research

Understanding how bacteria sense danger and form protective biofilms

Official title: Mechanisms of Bacterial Lysis Sensing

Funded at Carnegie-Mellon University · NIH-11392440 · Data updated 2026-11-12

Researchers are studying how bacteria detect threats and instinctively build protective biofilms, which could lead to better ways to treat infections and prevent biofilm-related problems.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCarnegie-Mellon University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startAugust 12, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$417,450
NIH project number5R35GM160020-02
Project IDNIH-11392440 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patients directly; potential indirect benefits come from improving infection control and antibiotic therapies.

Less likely to help

There is no direct patient participation in this basic science grant.

What this research studies

This project investigates a newly discovered mechanism called lysis sensing, where bacteria respond to signals from the death of related cells by forming biofilms. By combining molecular biology, biochemistry, advanced microscopy, and computational and automated methods, scientists will map the signals to the protective biofilm response. The work aims to connect what happens at the molecular level to how populations of bacteria behave in complex communities that resemble real-life microbiomes. The findings could reveal new targets to disrupt biofilms and improve antibiotic effectiveness.

Why it matters

Potential benefit: If successful, this research could lead to strategies that prevent or break up harmful biofilms, improving treatments for infections and reducing biofilm-related failures in clinical and industrial settings.

How similar studies have gone: Preliminary work has shown that lysis signaling influences biofilm formation, with ongoing studies expanding these findings.

Where this research is happening

  • Carnegie-Mellon University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Bridges, Andrew a. — Carnegie-Mellon University
  • Study coordinator: Bridges, Andrew a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.